ASAli Akbari Sari

Ali Akbari Sari

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Ali Akbari Sari has a total of 312 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Situation analysis of breast cancer screening in Iran: a mixed-methods study

    by Sajjad Dorri Kafrani, Ali Akbari Sari, Masud Yunesian, Leila Moadabshoar, Rajabali Daroudi

  • Open Access

    Contribution of Medication Expenditures to Catastrophic Health Expenditures in Iran: An Inequality Analysis

    by Abdoreza Mousavi, Rajabali Daroudi, Ali Akbari Sari, Masoomeh Gholami, Saeed Mohammadpour, Ali Akbar Fazaeli

    Objectives: Catastrophic health expenditures (CHE) is a well-established indicator of financial risk protection. This study aimed to examine the contribution of medication expenditure to CHE and the associated socioeconomic inequalities.Methods: Data were drawn from 6 nationally representative income and expenditure surveys covering the period 2019–2024. Using the budget share method, CHE was defined as out-of-pocket (OOP) health payments exceeding 25% of a household’s total consumption expenditure. The contribution of medication expenditures to CHE was then calculated as the difference in the proportion of households experiencing CHE with and without medication payments. Socioeconomic inequalities were quantified using the Concentration Index (CI), and decomposition analysis was conducted to identify the primary drivers of overall socioeconomic inequality in the contribution of medication expenditures to CHE.Results: During the study period, medications represented a substantial share of household health expenditures and contributed to CHE. In 2024, OOP spending on medications accounted for 31.2% of total health expenditures, while the contribution of medication expenditures to CHE was 1.28%. The CI indicated that the contribution of medication expenditures to CHE was concentrated among poorer households. Decomposition analysis further identified medium-sized households, male-headed households, households with employed heads, insured households, and urban households as the main contributors to this socioeconomic inequality.Conclusions: In Iran, OOP payments for medications constitute a substantial share of household healthcare expenditures and contribute to CHE. Because the roots of inequality extend beyond the healthcare system, addressing this issue requires a comprehensive, cross-sectoral strategy that integrates broader social and economic policies.

  • EQ-5D-5L Iranian population norms derived from the local value set during the COVID-19 pandemic

    by Somayeh Afshari, Thomas G. Poder, Rajabali Daroudi, Ali Akbari Sari, Hosein Ameri

    Purpose To derive the first population norms from the EQ-5D-5L in Iran during the COVID-19 pandemic. Methods Data were obtained from a study conducted in Iran during the COVID-19 pandemic in 2021. Face-to-face, computer-assisted interviews were conducted in a single visit, involving respondents from diverse sociodemographic backgrounds and providing a balanced representation of age and gender groups. Normative data for the EQ-5D-5L dimensions, EQ-5D-5L index values, and EuroQol visual analogue scale (EQ-VAS) scores were summarized by dimensions and disaggregated by age groups and gender. Multivariable logistic and Tobit regression models were used to investigate the associations between participants’ sociodemographic characteristics and their self-reported health, as measured by the EQ-5D-5L instrument, including responses on the five dimensions, EQ-5D-5L index values, and EQ-VAS scores. Results Among 1,004 participants, the mean index value and EQ-VAS score were 0.832 and 78.27, respectively. Full health was reported in 37.65% (EQ-5D-5L) and 6.18% EQ-VAS of participants. Anxiety/depression (AD) was the most frequently reported problem (47%), followed by pain/discomfort (36%). EQ-5D-5L index values and EQ-VAS scores decreased with age and increased with education, while women reported slightly worse health states than men. Multivariable logistic regressions showed that men had higher odds of reporting problems in most dimensions except in AD. Students had the lowest odds of reporting problems, whereas divorced individuals had the highest. Age, education, marital status, employment, and chronic illness were significantly associated with EQ-5D-5L index values and EQ-VAS scores (P < 0.001). Conclusion EQ-5D-5L index values and EQ-VAS scores were associated with age, educational level, marital status, employment status, and the presence of chronic illness. These norms provide valuable insights to support health funders and policymakers in making informed decisions about resource allocation.


  • Open Access

    Developing the Iranian health insurance benefit optimization model – the IR-HIBOM: a multicriteria decision analysis with decision rules for designing basic health insurance benefit packages

    by Ali Darvishi, Ali Akbari Sari, Mehdi Yaseri, Mohammadreza Mobinizadeh, Rajabali Daroudi

    Objectives: Prioritization of health technologies for insurance coverage is usually based on explicit and implicit criteria. This study presents the development of the multi-criteria decision analysis (MCDA) model, the Iranian Health Insurance Benefit Optimization Model (IR-HIBOM), to inform the design of basic health insurance benefit packages. Methods: An initial set of twenty-nine potential allocation criteria was identified through a review of available evidence and other relevant literature. Review of this set by three specialized panels yielded a final set of thirteen criteria. A cross-sectional survey using the best–worst scaling method was then fielded to 163 health system experts to evaluate their preferences regarding the relative importance of the allocation criteria. The mixed logit method was employed to determine the weight of the relative importance of each criterion. Subsequently, a multilevel criteria scoring framework was defined based on a review of similar models and input from a panel of five expert members of the study team. Finally, model’s appraisal was conducted. Results: Thirteen criteria, including relative safety, efficacy, disease severity, access to alternative health technologies, budget impacts, cost-effectiveness, quality of evidence, population size, age, job absenteeism, economic status, daily care needs, and ease-of-use/acceptance were selected. Cost-effectiveness and ease-of-use criteria had the highest and lowest relative importance weights, with 30.5 percent and 1 percent, respectively. Furthermore, scores were determined for the several levels of each criterion, and decision rules were defined for the cost-effectiveness and budget impact criteria. The final model’s appraisal, based on weighted scores of thirteen selected technologies, indicated that it was valid and applicable. Conclusions: The IR-HIBOM demonstrated its potential utility in the health resource allocation.


  • Open Access

    The New Model of Prioritizing Orphan Drugs: The Case Study for Hemophilia, SMA, CF and MS

    by Marita Mohammadshahi, Zahra Gharib-Naseri, Mohammadreza Mobinizadeh, Zeinab Fakoorfard, Farhad Hosseinzadeh Lotfi, Hamid Sharafi, Parisa Abooee, Ali Akbari Sari, Alireza Olyaeemanesh

    Background: Rare diseases, characterized by low prevalence and high complexity, pose significant challenges to health systems due to the uncertainty surrounding the best diagnostic methods and availability of effective treatments. Objectives: This study aimed to introduce new methods for prioritizing orphan drugs, with a pilot application to hemophilia, spinal muscular atrophy (SMA), cystic fibrosis (CF), and multiple sclerosis (MS). Methods: This quantitative research, conducted at Iran’s National Institute for Health Research from 2021 to 2023, employs multi-criteria decision-making models (MCDA) to evaluate the efficacy of health care technologies for "rare and hard to cure" diseases. A preliminary model was developed based on a pilot selection of seven medications, for which comprehensive data was extracted. The clinical efficacy was assessed using quality adjusted life years (QALY) as a metric. The model design was grounded on three critical factors: The annual cost of intervention per individual, the annual number of eligible patients for intervention, and the Proportion of expenses covered by the governmental budget. Additionally, the model incorporated various constraints and a regulatory coefficient, denoted as “w,” to enhance its robustness. Results: By running the model, the coverage of selected medications through model optimization, revealing the following percentages: Alemtuzumab (30%), ocrelizumab (30%), emicizumab (6%), dornase alfa (29%), tobramycin (2%), and spinraza (0.02%). Additionally, the corresponding monetary coverage in Iranian Rials is reported as follows: Alemtuzumab (27,144,000,000 IRR), ocrelizumab (109,645,200,000 IRR), emicizumab (17,360,490,000 IRR), dornase alfa (43,350,930,000 IRR), tobramycin (1,268,505,000 IRR), and spinraza (350,000,000 IRR). Conclusions: This model has tried to solve the shortcomings of the existing models regarding the prioritization of orphan drugs by combining different factors to improve access to essential treatments for rare diseases, although it can be generally asserted that no unique model can answer all policymakers’ questions regarding budget allocation of rare diseases and orphan products.

  • Open Access

    Discrete Choice Experiment in Evaluating Preferences for Physical Activity: A Mixed-Methods Study of Attributes and Their Levels

    by Mohammad Veisi, Rajabali Daroudi, Ramin Kordi, Ali Akbari Sari

    Background: Discrete choice experiment (DCE) has become a leading method for evaluating health sector preferences. Despite its common use in evaluating physical activity (PA) preference, there is a lack of consensus on the optimal attribute and level, and this step often lacks rigorous documentation. This study aimed to identify suitable attributes and ...


  • Open Access

    Assessment of the Effect of Community-Based Health Insurance Scheme on Health-Related Outcomes in Ethiopia: A Systematic Review

    by Abraham Gebrehiwot Yihdego, Maryam Tajvar, Ali Akbari Sari

    Background: We aimed to review the effect of community-based health insurance on health-related outcomes in Ethiopia. Methods: A systematic review was undertaken utilizing a major relevant published literature review from September 2017 to June 15, 2023. PubMed, Scopus, Web of Science, Science Direct, Google Scholar, Semantic Scholar, EMBASE, ProQuest, Hinari, and the Cochrane Library were used to search for relevant literature. Moreover, the Prisma flow model was used to select eligible findings. Results: Overall, 72% of the articles employed cross-sectional comparative study designs and procedures, and 36% of them employed samples ranging in size from 501 to 1000 participants. Furthermore, 76% were studied using descriptive statistics and logistic regression, whereas fewer utilized a random model, a probity model, or a correlation model. Similarly, 32% of the research used two-stage stratified sampling methods, and around 40% of the data revealed that the scheme increased healthcare utilization services. About 72 % of the reviewed study results showed that the scheme reduced catastrophic health expenditure and increases utilization of healthcare services. And the 20% reviewed studies stated that the CBHI boosts household satisfaction level. Moreover 12% of the reviewed studies stated that, CBHI increased QoL (quality of life). Conclusion: Most of the studies provide evidence of the positive effect of CBHI in Ethiopia. Mainly, its membership improved the utilization of health services and decreased the incidence of catastrophic health expenditures. Thus, all actors should cooperate to strengthen it to solve the effective attribute of the deprived value of health care and continuity of care delivery system related to the country's new policy.


  • Open Access

    Systematic Review of Tools and Approaches for Evaluating the Transferability of Health Technology Assessments Across Different Jurisdictions

    by Elham Ahmadnezhad, Mehrnaz Kheirandish, Ali Akbari-Sari, Arash Rashidian

    Background: This study aims to review tools that have been developed for the transferability of health technology assessment (HTA) information to different countries. HTA is increasingly being used as a tool in health policy decision-making, but its complexity and lack of local expertise have limited its usage in many countries. The World Health Organization (WHO) has taken measures to encourage countries to conduct and use HTA, including through resolutions from the Eastern Mediterranean (EM) Regional Committee in 2019. However, due to limitations in national technical capacities, there is a need to adapt HTA information from other settings to fit the specific context of each country. Therefore, this study aims to systematically review the tools that have been developed for HTA transferability and assess their strengths and limitations. Methods: The systematic review included studies that introduced tools, methods, and frameworks for transferability of HTA information across jurisdictions. Databases such as MEDLINE, EMBASE, Cochrane Library, Epistemonikos, Web of Science, health economic database, Scopus, and Google Scholar were searched, along with relevant bibliographies. The data was extracted and synthesized using both tabulation and narrative approaches. The evaluation of the tools involved assessing various criteria, such as user-friendliness, efficiency in screening, and considerations regarding transferability factors. Results: A total of 10 375 documents were evaluated, resulting in 17 studies that met the inclusion criteria. These 17 studies consisted of 13 newly developed tools/methods that were appraised. The majority of the models were checklists, with only a few deemed suitable for full HTA. Three models have been validated through published studies, but there is no evidence of utilization in the countries of the EM region. Conclusion: While the existing tools provide valuable resources for evaluating transferability, there remains a need for a more comprehensive tool to support decision-makers in low-resource settings considering country context and capacity.


  • Open Access

    The prevalence of HTLV-1 co-infection among people living with HIV in a tertiary care hospital in Tehran: a cross-sectional study

    by Elnaz Shahmohamadi, Ali Akbari Sari, Esmaeil Mehraeen, Malihe Hassan Nezhad, Amirali Karimi, Pegah Mirzapour, Peyman Mirghaderi, Zahra Pashaei, Hossein Keivani, Minoo Mohraz, et al.

    Introduction: Human immunodeficiency virus (HIV) and human T cell leukemia/lymphoma virus type 1 (HTLV-1) share similar routes of transmission and both target T cells. HTLV-1 may negatively affect the course of disease in people living with HIV, but previous evidence is conflicting....